Exploring potential influencing factors of inadherence to specialist aftercare and long-term medication in patients with acromegaly.

Autor: Siegel S; Department of Neurosurgery and Spine Surgery, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany., Giese S; Department of Neurosurgery, University of Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany., Honegger J; Department of Neurosurgery, University of Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany., Friedel AL; Department of Neurosurgery and Spine Surgery, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.; Institute for Medical Education, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany., Grzywotz A; Department of Neurosurgery and Spine Surgery, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany., Wrede KH; Department of Neurosurgery and Spine Surgery, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany., Sure U; Department of Neurosurgery and Spine Surgery, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany., Unger N; Department of Endocrinology, Diabetes and Metabolism, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany., Kreitschmann-Andermahr I; Department of Neurosurgery and Spine Surgery, University of Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. ilonka.kreitschmann@uk-essen.de.
Jazyk: angličtina
Zdroj: Pituitary [Pituitary] 2024 Aug; Vol. 27 (4), pp. 403-415. Date of Electronic Publication: 2024 May 24.
DOI: 10.1007/s11102-024-01400-4
Abstrakt: Purpose: To improve the understanding of adherence as one major factor of disease control in acromegaly patients, we systematically assessed patients' motivations to adhere to advised follow-up schedules and recommended medication for acromegaly.
Methods: Cross-sectional, postal questionnaire study on adult patients with acromegaly, operated upon a growth hormone producing pituitary adenoma more than 1 year ago in two tertiary treatment centers. We assessed demographic and clinical characteristics, disease status, adherence to acromegaly medication and/or aftercare, and the five dimensions defined by the World Health Organization influencing adherence. Wherever applicable, we included validated short scales. The answers of 63 patients (33 f, 30 m; mean age 56.1 y) were analyzed.
Results: Patients with problems in adherence to aftercare had a significantly lower subjective symptomload than those adherent to aftercare (p = 0.026) and a lower perceived need for treatment (p = 0.045). Patients with adherence problems to medication had a higher subjective symptomload than those without (p = 0.056). They also tended to have shorter consultations, were significantly more often dissatisfied with the duration of their medical consultations (42% vs 4.8%, p = 0.019) and tended to find that their physician explained potential difficulties with adherence less well than patients without adherence problems (p = 0.089).
Conclusions: To our knowledge, this is the first study which explored adherence to medication and aftercare in patients with acromegaly, taking into account potential influencing factors from all areas defined by the WHO model of adherence. Of the modifiable factors of adherence, patient-doctor relationship seemed to play a crucial role and could be one leverage point to improve adherence.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: